Dipivefrine
From Wikipedia, the free encyclopedia
This article is about the drug. It is not to be confused with Propyne.
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
[2-(2,2-dimethylpropanoyloxy)-4- (1-hydroxy-2-methylamino-ethyl)- phenyl] 2,2-dimethylpropanoate
|
|
| Clinical data | |
| Trade names | Propine |
| AHFS/Drugs.com | International Drug Names |
| MedlinePlus | a686005 |
| Pregnancy category |
|
| Identifiers | |
| CAS Number | 52365-63-6  |
| ATC code | S01EA02 |
| PubChem | CID 3105 |
| IUPHAR/BPS | 7166 |
| DrugBank | DB00449 |
| ChemSpider | 2994 |
| UNII | 8Q1PVL543G |
| KEGG | D02349 |
| ChEBI | CHEBI:4646 |
| ChEMBL | CHEMBL1201262  |
| Chemical data | |
| Formula | C19H29NO5 |
| Molar mass | 351.437 g/mol |
|
|
|
|
| (what is this?) (verify) |
Dipivefrin (trade name Propine) is a prodrug of epinephrine, and is used to treat open-angle glaucoma.[1] It is available as a 0.1% ophthalmic solution.
Mechanism of action[edit]
The drug when applied over the cornea, penetrates it and is then hydrolysed to epinephrine by the esterases. It increases uveosacral outflow and also reduces aqueous formation (an α1 and α2 mediated action), thus reducing the intraocular pressure. It also increases the hydraulic conductivity of trabecular filtering cells (a β2 mediated action). It is preferred to epinephrine because it is longer acting, more consistent in its action and has better ocular tolerance.[1]
References[edit]
- ^ a b KD Tripari MD. Essentials of Medical Pharmacology (5 ed.). Jaypee Brothers Medical Publishers(P) Ltd. p. 88. ISBN 81-8061-187-6.
 |
This article needs additional citations for verification. (March 2010) |
|
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
